SCHEMBL7892197

SCHEMBL7892197

O=c1c2cccnc2c(-c2ccccc2)nn1NC(=S)NCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 1/20 0.42
▸ GAA P10253 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ ALOX12 P18054 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ PDE4A P27815 2/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ PDE3B Q13370 1/20 0.41
▸ PDE3A Q14432 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7894602 0.87 ALDH1A1 (0.51) GAAMAPTALDH1A1ALOX12HPGD
SCHEMBL7892210 0.74 ALDH1A1 (0.52) GAAALDH1A1HPGDPOLBMEN1
SCHEMBL7365917 0.73 ALDH1A1 (0.70) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL7892193 0.73 PDE4A (0.41) LIPGGAAALDH1A1HPGDPDE4A
SCHEMBL7894711 0.70 ADORA1 (0.46) GAAALDH1A1HPGDPDE4APDE4B
SCHEMBL9168570 0.69 NPSR1 (0.56) GAAALDH1A1PDE4APDE4BPDE4C
SCHEMBL7362478 0.68 PDE4A (0.77) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL7361626 0.67 ALDH1A1 (0.56) MAPTALDH1A1HPGDPDE4APDE4B
SCHEMBL1252544 0.67 PDE4A (0.50) GAAALDH1A1HPGDPDE4APDE4B
SCHEMBL7363014 0.67 ALDH1A1 (0.59) ALDH1A1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180629-B1 INDUCING OR PROMOTING APOPTOSIS AND FOR ARRESTING UNCONTROLLED NEOPLASTIC CELL PROLIFERATION, INCLUDING PRECANCEROUS AND CANCEROUS LESIONS CELL PATHWAYS, INC. 2001-01-30 — — US disclosed
Send feedback